Total Payments
$4,232
2024 Payments
$332.31
Companies
17
Transactions
165
Medicare Patients
336
Medicare Billing
$101,810
Payment Breakdown by Category
Food & Beverage$4,225 (99.8%)
Education$7.12 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,225 | 164 | 99.8% |
| Education | $7.12 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $963.81 | 12 | $0 (2024) |
| ABBVIE INC. | $538.43 | 32 | $0 (2024) |
| Axsome Therapeutics, Inc. | $462.93 | 7 | $0 (2024) |
| Shire North American Group Inc | $445.76 | 31 | $0 (2019) |
| Lundbeck LLC | $363.62 | 18 | $0 (2022) |
| Allergan, Inc. | $278.57 | 18 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $239.55 | 16 | $0 (2021) |
| Alkermes, Inc. | $207.46 | 7 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $124.99 | 1 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $115.66 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $332.31 | 6 | Teva Pharmaceuticals USA, Inc. ($124.99) |
| 2023 | $923.88 | 19 | Axsome Therapeutics, Inc. ($415.41) |
| 2022 | $307.34 | 19 | ABBVIE INC. ($218.67) |
| 2021 | $434.07 | 22 | AbbVie Inc. ($239.76) |
| 2020 | $246.86 | 13 | Lundbeck LLC ($111.79) |
| 2019 | $601.10 | 20 | Otsuka America Pharmaceutical, Inc. ($386.64) |
| 2018 | $455.72 | 29 | Shire North American Group Inc ($166.61) |
| 2017 | $930.75 | 37 | Otsuka America Pharmaceutical, Inc. ($318.69) |
All Payment Transactions
165 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $116.78 | General |
| Category: PSYCHIATRY | ||||||
| 08/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Neurology | ||||||
| 01/12/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Neurology | ||||||
| 12/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: INSOMNIA | ||||||
| 11/30/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $121.36 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/15/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $99.09 | General |
| Category: Neuroscience | ||||||
| 10/26/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $121.87 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/25/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Psychology/Psychiatric | ||||||
| 07/28/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: INSOMNIA | ||||||
| 06/30/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: CNS | ||||||
| 06/09/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: CNS | ||||||
| 06/09/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $3.95 | General |
| Category: CNS | ||||||
| 05/26/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: INSOMNIA | ||||||
| 05/21/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $92.74 | General |
| Category: CNS | ||||||
| 05/11/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $100.35 | General |
| Category: PSYCHIATRY | ||||||
| 04/21/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: CNS | ||||||
| 03/10/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: CNS | ||||||
| 02/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: NEUROSCIENCE | ||||||
| 02/03/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: CNS | ||||||
| 01/26/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $121.87 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/20/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 90 | 434 | $65,100 | $32,232 |
| 2022 | 2 | 92 | 318 | $47,700 | $24,672 |
| 2021 | 2 | 82 | 305 | $45,750 | $23,081 |
| 2020 | 2 | 72 | 296 | $44,400 | $21,825 |
Total Patients
336
Total Services
1,353
Medicare Billing
$101,810
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 217 | $32,550 | $21,040 | 64.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 45 | 217 | $32,550 | $11,192 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 159 | $23,850 | $15,971 | 67.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 46 | 159 | $23,850 | $8,701 | 36.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 153 | $22,950 | $14,853 | 64.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 41 | 152 | $22,800 | $8,228 | 36.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 148 | $22,200 | $13,175 | 59.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 36 | 148 | $22,200 | $8,649 | 39.0% |
About Dr. Marc Reiner, MD
Dr. Marc Reiner, MD is a Psychiatry healthcare provider based in Atascadero, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003980772.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Reiner, MD has received a total of $4,232 in payments from pharmaceutical and medical device companies, with $332.31 received in 2024. These payments were reported across 165 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($4,225).
As a Medicare-enrolled provider, Reiner has provided services to 336 Medicare beneficiaries, totaling 1,353 services with total Medicare billing of $101,810. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Atascadero, CA
- Active Since 11/17/2006
- Last Updated 03/23/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003980772
Products in Payments
- VRAYLAR (Drug) $697.87
- REXULTI (Drug) $689.85
- Auvelity (Drug) $443.76
- VYVANSE (Drug) $351.31
- ABILIFY MAINTENA (Drug) $332.03
- BRINTELLIX (Drug) $211.85
- Trintellix (Drug) $209.09
- ARISTADA (Drug) $207.46
- TRINTELLIX (Drug) $173.67
- MYDAYIS (Drug) $133.03
- UZEDY (Drug) $124.99
- APTIOM (Drug) $115.66
- INVEGA SUSTENNA (Drug) $99.09
- Evekeo (Drug) $98.30
- Dayvigo (Drug) $78.30
- QUVIVIQ (Drug) $64.59
- CAPLYTA (Drug) $44.05
- VIBERZI (Drug) $19.48
- Sunosi (Drug) $19.17
- BELSOMRA (Drug) $18.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.